Today patients in MSF projects, and millions of other people around the world, rely on affordable, generic medicines made in India to stay alive and healthy. India is currently negotiating several free trade agreements that could jeopardise the operations of the country’s generic medicines industry. The Access Campaign’s Roshan Joseph explains what’s at stake and what MSF is doing about it.
